130 related articles for article (PubMed ID: 31468430)
21. Identification of competitive inhibitors of the human taurine transporter TauT in a human kidney cell line.
Richter M; Moroniak SJ; Michel H
Pharmacol Rep; 2019 Feb; 71(1):121-129. PubMed ID: 30612046
[TBL] [Abstract][Full Text] [Related]
22. Blunted apoptosis of erythrocytes from taurine transporter deficient mice.
Lang PA; Warskulat U; Heller-Stilb B; Huang DY; Grenz A; Myssina S; Duszenko M; Lang F; Häussinger D; Vallon V; Wieder T
Cell Physiol Biochem; 2003; 13(6):337-46. PubMed ID: 14631140
[TBL] [Abstract][Full Text] [Related]
23. Gene expression of taurine transporter and taurine biosynthetic enzymes in brain of rats with acute or chronic hyperosmotic plasma. A comparative study with gene expression of myo-inositol transporter, betaine transporter and sorbitol biosynthetic enzyme.
Bitoun M; Tappaz M
Brain Res Mol Brain Res; 2000 Apr; 77(1):10-8. PubMed ID: 10814827
[TBL] [Abstract][Full Text] [Related]
24. Physiological significance of the taurine transporter and taurine biosynthetic enzymes in 3T3-L1 adipocytes.
Takasaki M; Satsu H; Shimizu M
Biofactors; 2004; 21(1-4):419-21. PubMed ID: 15630240
[TBL] [Abstract][Full Text] [Related]
25. RNA interference-mediated silencing of the p53 tumor-suppressor protein drastically increases apoptosis after inhibition of endogenous fatty acid metabolism in breast cancer cells.
Menendez JA; Lupu R
Int J Mol Med; 2005 Jan; 15(1):33-40. PubMed ID: 15583825
[TBL] [Abstract][Full Text] [Related]
26. Biallelic mutation of human
Preising MN; Görg B; Friedburg C; Qvartskhava N; Budde BS; Bonus M; Toliat MR; Pfleger C; Altmüller J; Herebian D; Beyer M; Zöllner HJ; Wittsack HJ; Schaper J; Klee D; Zechner U; Nürnberg P; Schipper J; Schnitzler A; Gohlke H; Lorenz B; Häussinger D; Bolz HJ
FASEB J; 2019 Oct; 33(10):11507-11527. PubMed ID: 31345061
[TBL] [Abstract][Full Text] [Related]
27. Imidazole-4-acetic acid, a new lead structure for interaction with the taurine transporter in outer blood-retinal barrier cells.
Valembois S; Krall J; Frølund B; Steffansen B
Eur J Pharm Sci; 2017 May; 103():77-84. PubMed ID: 28259832
[TBL] [Abstract][Full Text] [Related]
28. Taurine transporter gene expression in peripheral mononuclear blood cells of type 2 diabetic patients.
Bianchi L; Lari R; Anichini R; De Bellis A; Berti A; Napoli Z; Seghieri G; Franconi F
Amino Acids; 2012 Jun; 42(6):2267-74. PubMed ID: 21739148
[TBL] [Abstract][Full Text] [Related]
29. Localization of the membrane defect in transepithelial transport of taurine by parallel studies in vivo and in vitro in hypertaurinuric mice.
Chesney RW; Scriver CR; Mohyuddin F
J Clin Invest; 1976 Jan; 57(1):183-93. PubMed ID: 1245598
[TBL] [Abstract][Full Text] [Related]
30. Functional expression and subcellular localization of the taurine transporter TauT in murine neural precursors.
Hernández-Benítez R; Pasantes-Morales H; Pinzón-Estrada E; Ramos-Mandujano G
Dev Neurosci; 2010; 32(4):321-8. PubMed ID: 21160187
[TBL] [Abstract][Full Text] [Related]
31. Functional characterization and regulation of the taurine transporter and cysteine dioxygenase in human hepatoblastoma HepG2 cells.
Satsu H; Terasawa E; Hosokawa Y; Shimizu M
Biochem J; 2003 Oct; 375(Pt 2):441-7. PubMed ID: 12871209
[TBL] [Abstract][Full Text] [Related]
32. Regulation of TauT by cisplatin in LLC-PK1 renal cells.
Han X; Chesney RW
Pediatr Nephrol; 2005 Aug; 20(8):1067-72. PubMed ID: 15942793
[TBL] [Abstract][Full Text] [Related]
33. Selective killing of human breast cancer cells by the styryl lactone (R)-goniothalamin is mediated by glutathione conjugation, induction of oxidative stress and marked reactivation of the R175H mutant p53 protein.
Punganuru SR; Madala HR; Arutla V; Srivenugopal KS
Carcinogenesis; 2018 Dec; 39(11):1399-1410. PubMed ID: 30010803
[TBL] [Abstract][Full Text] [Related]
34. CTLA-4 blockade enhances the therapeutic effect of an attenuated poxvirus vaccine targeting p53 in an established murine tumor model.
Espenschied J; Lamont J; Longmate J; Pendas S; Wang Z; Diamond DJ; Ellenhorn JD
J Immunol; 2003 Mar; 170(6):3401-7. PubMed ID: 12626601
[TBL] [Abstract][Full Text] [Related]
35. Ionomycin restores taurine transporter activity in cyclosporin-A treated macrophages.
Kim HW; Lee EJ; Kim WB; Kim BK
Adv Exp Med Biol; 2000; 483():127-35. PubMed ID: 11787589
[TBL] [Abstract][Full Text] [Related]
36. Maternal obesity is associated with a reduction in placental taurine transporter activity.
Ditchfield AM; Desforges M; Mills TA; Glazier JD; Wareing M; Mynett K; Sibley CP; Greenwood SL
Int J Obes (Lond); 2015 Apr; 39(4):557-64. PubMed ID: 25547282
[TBL] [Abstract][Full Text] [Related]
37. Knockdown of c-Myc expression by RNAi inhibits MCF-7 breast tumor cells growth in vitro and in vivo.
Wang YH; Liu S; Zhang G; Zhou CQ; Zhu HX; Zhou XB; Quan LP; Bai JF; Xu NZ
Breast Cancer Res; 2005; 7(2):R220-8. PubMed ID: 15743499
[TBL] [Abstract][Full Text] [Related]
38. Death-associated protein kinase 1 promotes growth of p53-mutant cancers.
Zhao J; Zhao D; Poage GM; Mazumdar A; Zhang Y; Hill JL; Hartman ZC; Savage MI; Mills GB; Brown PH
J Clin Invest; 2015 Jul; 125(7):2707-20. PubMed ID: 26075823
[TBL] [Abstract][Full Text] [Related]
39. High expression of the taurine transporter TauT in primary cilia of NIH3T3 fibroblasts.
Christensen ST; Voss JW; Teilmann SC; Lambert IH
Cell Biol Int; 2005 May; 29(5):347-51. PubMed ID: 15914036
[TBL] [Abstract][Full Text] [Related]
40. Identification of a new class of natural product MDM2 inhibitor: In vitro and in vivo anti-breast cancer activities and target validation.
Qin JJ; Wang W; Voruganti S; Wang H; Zhang WD; Zhang R
Oncotarget; 2015 Feb; 6(5):2623-40. PubMed ID: 25739118
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
